Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Exp Neurol. 2018 Mar 11;305:13–25. doi: 10.1016/j.expneurol.2018.03.010

Table 1.

Subject Data

Subject Sex Age (years) Treatment Group Lesion Hemisphere BrdU Survival Time (days) Recovery Time (days)* Mean Grasp Assessment* Supplier
SM014j M 8.5 Placebo L 110 54 7.68 CPRC
SM018j M 9.6 Placebo L 92 96 6.46 CPRC
SM020j M 9.3 Placebo R 106 96 6.58 CPRC
SM022j M 10.6 Placebo R 138 96 6.46 CPRC
SM016j M 10.1 hUTC Treated L 116 56 7.88 CPRC
SM017j M 8.6 hUTC Treated L 99 35 7.72 CPRC
SM021j M 11.5 hUTC Treated R 111 51 7.80 CPRC
SM024j M 12.1 hUTC Treated L n/a 48 7.86 YNPRC

Abbreviations: hUTC, human umbilical tissue derived cells (CNTO0007, Advanced Technologies and Regenerative Medicine, LLC, New Brunswick, NJ). CPRC, Caribbean Primate Research Center, University of Puerto Rico, San Juan, PR. YNPRC, Yerkes National Primate Research Center, Emory University, Atlanta, GA. BrdU, Bromodeoxyuridine.

*

Previously published data in Moore et al., 2013 (used in correlation studies in the current study)